Dr. Yamil H. Kouri, MD

Dr. Kouri practices at HCA Florida Blake Hospital in Bradenton, Florida, part of HCA Healthcare.

Dr. Kouri's NPI, 1770566945, was assigned on November 22, 2005. Dr. Kouri graduated from University of Puerto Rico, Medical Sciences Campus in 1985. Dr. Kouri holds Florida license ME158230.

Dr. Kouri's primary practice is HCA Florida Blake Hospital, at 2020 59th St W, Bradenton, FL 34209 in Manatee County. The practice phone is (941) 798-6110.

Dr. Kouri's primary practice is HCA Florida Blake Hospital in Bradenton, Florida, part of HCA Healthcare. Dr. Kouri is also affiliated with Manatee Memorial Hospital. The medical group on file is MaxHealth Primary Care. Dmand AI also links Dr. Kouri to 4 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kouri practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kouri's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kouri is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Kouri's licenses on file in 5 states: Florida, New Hampshire, Massachusetts, New York and Illinois.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer, lymphoma and multiple myeloma among the conditions Dr. Kouri treats.

CMS data shows 31,860 Medicare services from Dr. Kouri across 24 procedure codes in 2024, for 341 Medicare patients. Medicare paid $252,544 for them.

CMS counts 341 Medicare patients who saw Dr. Kouri in 2024. The largest group is 75 to 84, with 141 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kouri's median patient age at 74, with 50% women.

In 2024, Dr. Kouri wrote 764 Medicare Part D claims for 154 patients. 66% of them were for generic drugs. CMS names the drug for 469 of them, across 25 drugs with 11 or more claims each, at $1,805,858 in total drug cost. In 2023, CMS named 251 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Kouri for performance year 2024, reported individually. Dr. Kouri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kouri as offering telehealth.

Dmand AI links 13 papers to Dr. Kouri. The most frequent topics are CD4 Antigens, Antibodies, Monoclonal and HIV-1. Dr. Kouri has published most often in Kyobu Geka. Dr. Kouri's most frequent co-author is Ross Basch, MD.

CMS Open Payments shows 687 general payments to Dr. Kouri from 72 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 41% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $4,498.

Dmand AI lists 1 award for Dr. Kouri, most recently CMS Stage 1 EHR in 2013.

Dr. Kouri graduated from University of Puerto Rico, Medical Sciences Campus in 1985. Dr. Kouri is a member of ACP.

Dr. Kouri is in network with 12 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.